CCR5 and relapsing-remitting multiple sclerosis: However, in RRMS patients, CCR5 expression is upregulated on intermediate monocytes, and their corresponding ligands are highly expressed in inflammatory lesions of MS, resulting in mass infiltration into the perivascular space [35].